KassondraSuzanneGrzankowskiMDFACOG

[Pronunciation: gran-kow-ski]

Obstetrics & Gynecology • San Antonio, TX

Gynecologic Oncology

Physician

Join to view full profile

Dr. Grzankowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grzankowski's full profile

Already have an account?

Office
8715 Village Dr Ste 116
San Antonio, TX 78217
Phone+1 210-593-4980

Fax+1 210-593-4842

Summary

Dr. Kassondra Grzankowski, "Dr. G", is a Gynecologic Oncologist who provide comprehensive women's cancer care including surgery, chemotherapy, and radiation, if required, for ovarian, uterine, endometrial, cervical, vulvar, and vaginal cancers. Dr. G is a fellowship trained Gynecologic Oncologist board certified in Obstetrics and Gynecology.

Education & Training

University at BuffaloFellowship, Gynecologic Oncology, 2012 - 2016
University of HawaiiResidency, Obstetrics and Gynecology, 2008 - 2012
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008

Certifications & Licensure

AZ State Medical License 2016 - 2026
TX State Medical License 2020 - 2026
NY State Medical License 2012 - 2025
HI State Medical License 2008 - 2012
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

59 citations
Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer.
Kelly L. Singel, K.S. Grzankowski, A. Nazmul H. Khan, Melissa J. Grimm, Anthony C. D'Auria
British Journal of Cancer. 2019-01-01
Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.
Kassondra S Grzankowski, J Brian Szender, Chandra L Spring-Robinson, Shashikant B Lele, Kunle O Odunsi
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016-10-01
3 citations
Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.
K.S. Grzankowski, J. Brian Szender, Chandra L. Spring-Robinson, Shashikant Lele, Kunle Odunsi
International Journal of Gynecological Cancer. 2016-10-01

Press Mentions

Cervical Cancer: What You Need to KnowOctober 24th, 2017

External Links

My Website:https://www.drggynonc.com/